PBBM signs law creating Virology and Vaccine Institute of the Philippines

President Ferdinand Marcos Jr. has signed into law Republic Act No. 12290, establishing the Virology and Vaccine Institute of the Philippines (VIP) as a national research center.

The VIP aims to bolster the country's capacity to study viruses and develop vaccines and diagnostics against infectious diseases, adopting the One Health approach.

Signed on 12 September 2025, this measure is seen as a landmark step in fortifying the Philippines' health security and scientific innovation.

Under the new law, the VIP was tasked to conduct vaccine research from discovery to pre-clinical phases, carrying out discovery programs in virology, molecular biology, and bioinformatics.

It will also build partnerships with local and international research institutions and invest in advanced virology infrastructure, including high-containment facilities, biobanks, and genome laboratories.

The institute will provide training for experts, technical assistance to research communities, and disseminate evidence-based policy recommendations.

President Marcos stated that the establishment of the VIP marks a transformative step in safeguarding the health of our people and ensuring preparedness against emerging health threats.